Mupirocin
- Product NDC
- 70771-1981
- 11-digit product format
- 707711981
- Labeler code
- 70771
- Product ID
- 70771-1981_93a19ca4-ca3b-4338-917f-8c0920628574
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Mupirocin
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Zydus Lifesciences Limited
- Application
- ANDA218361
- Marketing category
- ANDA
- Marketing start
- 2026-10-10
- Substance
- MUPIROCIN CALCIUM
- Active strength
- 20 mg/g
- Pharmacologic classes
- RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Source provenance: Browse the complete Orange Book source catalog.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Mupirocin
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MUPIROCIN CALCIUM | 20 mg/g |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70771-1981-1 | 70771198101 | 1 TUBE in 1 CARTON (70771-1981-1) / 15 g in 1 TUBE | 1 tube | 2026-10-10 | No | No | Current |
| 70771-1981-2 | 70771198102 | 1 TUBE in 1 CARTON (70771-1981-2) / 30 g in 1 TUBE | 1 tube | 2026-10-10 | No | No | Current |